Belimumab for the Treatment of Early Diffuse Systemic Sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|70|2|308-316

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.70, Iss.2, 2018-02, pp. : 308-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Early Rituximab Treatment in a Case of Systemic Lupus Erythematosus with Potentially Fatal Diffuse Alveolar Hemorrhage

By  

Respiration, Vol. 89, Iss. 1, 2014-12 ,pp. : 62-65

Karger

Access to resources Recommend Favorite

A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 11, 2015-11 ,pp. : 3004-3015

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of paraffin bath treatment in patients with systemic sclerosis

By Sandqvist Gunnel   Åkesson Anita   Eklund Mona  

Disability and Rehabilitation, Vol. 26, Iss. 16, 2004-08 ,pp. : 981-987

Informa Healthcare

Access to resources Recommend Favorite

Systemic sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 2, 2018-02 ,pp. : 128-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

BUDGET IMPACT ANALYSIS OF BELIMUMAB IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

By  

International Journal of Technology Assessment in Health Care, Vol. 32, Iss. 5, 2016-12 ,pp. : 348-354

Cambridge University Press

Access to resources Recommend Favorite